Tiziana Life Sciences Ltd

Stage 1 · Basing · week 1

As of Oct 22, 2026, Tiziana Life Sciences is in Stage 1, the basing phase, now in its first week (since Oct 16, 2026). It closed at $1.00, 48.7% below its 52-week high and below its 200-day average, which is falling.

$1.00

+2.07% today

$127M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Basing, not in an uptrend yet

Setup score

—

Momentum

Accelerating ⇈

Edge

—

Is TLSA early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 24w

S2 20w

S2 31w

S4 18w

S4 16w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S4 5w → S1 7w → S4 24w → S1 5w → S2 20w → S3 7w → S2 2w → S3 4w → S4 7w → S1 2w → S2 31w → S3 12w → S4 18w → S1 5w → S4 16w → S1 1w current

Total tracked: 166 weeks across 16 stage runs.

TLSA among Biotechnology346th of 591 by relative strength

All 591 →

Stocks in Biotechnology ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	GTBPGT Biopharma, Inc.	Stage 2 · wk 7	99	−22.3%
2	IOVAIovance Biotherapeutics, Inc.	Stage 2 · wk 18	99	+38.8%
3	SLSSELLAS Life Sciences Group, Inc.	Stage 3 · wk 4	99	−1.5%
4	MRNAModerna, Inc.	Stage 2 · wk 17	99	+11.3%
5	TWSTTwist Bioscience Corporation	Stage 2 · wk 39	99	−14.5%
6	KODKodiak Sciences Inc	Stage 2 · wk 4	99	+172.1%
7	ERASErasca, Inc.	Stage 3 · wk 5	99	+0.7%
8	CLYMClimb Bio, Inc.	Stage 3 · wk 3	99	−15.8%
…346	TLSATiziana Life Sciences Ltd	Stage 1 · wk 1	25	−4.8%

vs 52W High

-48.7%

$0.77 lo$1.95 hi

48.7% below 52W high

Stock is basing below old highs. A volume-backed breakout to new highs would be the Stage 2 signal to watch.

Stage Maturity

Week 1

1w13w26w

Week 1, early base

How long this stock has been basing. Longer bases can produce stronger breakouts, but the breakout itself is the signal.

vs 200 DMA

-18.7%

200 DMA: $1.23 · sloping down

Stock is testing its 200 DMA as part of the base. Reclaiming and holding above it is a key Stage 2 prerequisite.

Rel Volume

0.64x

vs 50-day avg

Volume in Stage 1 basing is typically quiet. A surge in volume on an upside breakout is the signal to watch.

Trend Health

↑ ⇈

Short-term trend rising strongly, and accelerating

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-4.8%

+12.4%

-18.7%

YTD

-37.5%

-47.1%

Scan Membership

Breakout Watch

Latest: 2025-03-19

6 appearances in last 60 days. First seen: 2020-05-15.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S1

Wk 1 · Vol 0.64x

2026-10-21S1

Wk 1 · Vol 0.54x

2026-10-20S1

Wk 1 · Vol 0.38x

2026-10-19S1

Wk 1 · Vol 0.42x

2026-10-16S14→1

Wk 1 · Vol 0.68x

2026-10-15S4

Wk 17 · Vol 0.32x

2026-10-14S4

Wk 16 · Vol 0.69x

2026-10-13S4

Wk 16 · Vol 0.55x

2026-10-12S4

Wk 16 · Vol 0.64x

2026-10-09S4

Wk 16 · Vol 2.90x

2026-10-08S4

Wk 16 · Vol 0.54x

2026-10-07S4

Wk 15 · Vol 0.47x

Moving averages & range

50 DMA

$1.03

200 DMA

$1.23

52W High

$1.95

52W Low

$0.77

5D Low

$0.98

Resistance levels (recent highs)

20d High

$1.19

60d High

$1.19

120d High

$1.61

250d High

$1.95

Next resistance

+19.0%

to 20d High

ROE

-780.6%

Profit margin 0.0%

Dividend Yield

0.00%

P/B -47.6

Tiziana Life Sciences: quick answers

What stage is Tiziana Life Sciences in?

As of Oct 22, 2026, Tiziana Life Sciences (TLSA) is in Stage 1, the basing phase. It entered Stage 1 on Oct 16, 2026 and is in its first week there. What the four stages mean

Is Tiziana Life Sciences in an uptrend?

Not yet. Tiziana Life Sciences is in Stage 1, a base that can come before an uptrend. It trades 18.7% below its 200-day average, which is falling.

How far is Tiziana Life Sciences from its 52-week high?

Tiziana Life Sciences closed at $1.00 on Oct 22, 2026, 48.7% below its 52-week high of $1.95. Its 52-week low is $0.77.

How has Tiziana Life Sciences performed over the past year?

As of Oct 22, 2026, Tiziana Life Sciences is down 47.1% over the past year and down 37.5% so far in 2026.

Which sector and industry is Tiziana Life Sciences in?

Tiziana Life Sciences is in the Biotechnology industry, part of the Health Care sector.

About this companyHealth Care· Biotechnology

Tiziana Life Sciences Ltd, together with its subsidiaries, engages in the research and development of therapies for neurodegenerative and neuroinflammatory diseases in the United Kingdom and internationally. It develops Foralumab TZLS-401, a human anti-CD3 monoclonal antibody, which is Phase II clinical trial for the treatment of non-active secondary progressive multiple sclerosis, Alzheimer's disease, multi system atrophy, and amyotrophic lateral sclerosis; and TZLS-501, a human anti-IL-6R monoclonal antibody for the treatment of autoimmune and inflammatory diseases. The company is headquartered in London, the United Kingdom.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.